https://www.selleckchem.com/pr....oducts/ci994-tacedin
We evaluated the in vitro activity of eravacycline and cefoperazone/sulbactam against 42 XDR and 58 PDR Acinetobacter baumannii isolates from blood and bronchoalveolar infections. The minimum and maximum MICs for eravacycline were 0.125 and 4 mg/L, respectively. The MIC50 was 2 mg/L and the MIC90 was 3 mg/L. The minimum and maximum MICs for cefoperazone/sulbactam were 24 and 256 mg/L, respectively. The MIC50 and MIC90 were both 256 mg/L. These novel agents were not adequate for the treatment of A. baumannii infections
Like
Comment
Share
